HopeStage
Back to all studies
UnknownNCT05809609

Glutamate Emotion Memory Study

Medication studyAges 20–60United KingdomDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 20 years to 60 years.

Listed locations
OxfordSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 1, 2022
Recruitment status
Unknown
Enrollment listed in the registry
60
Sponsor
University of Oxford
Sponsor type
University
Study type
Drug
Intervention type
Drug, Other
Locations
United Kingdom
Age range
From 20 Years to 60 Years
Official registry ID
NCT05809609
Official title
Show the full official title

Does Modulation of Glutamate Transmission in the Brain Using a Sub-anaesthetic Dose of Ketamine Affect Autobiographical Memory, Emotional Processing and Decision-making in Treatment-resistant Depression?

Recruitment & locations

Status unknown

Oxford

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Oxford, a university.

Does this study involve medication?

Yes. The study involves medication, including Ketamine Hydrochloride.

Who can participate?

Listed age limits: 20 years to 60 years.

Want to explore more studies?

Explore studies